2020 International Society of Hypertension Global Hypertension Practice Guidelines.

Document reviewers: Hind Beheiry (Sudan), Irina Chazova (Russia), Albertino Damasceno (Mozambique), Anna Dominiczak (UK), Anastase Dzudie (Cameroon), Stephen Harrap (Australia), Hiroshi Itoh (Japan), Tazeen Jafar (Singapore), Marc Jaffe (USA), Patricio Jaramillo-Lopez (Colombia), Kazuomi Kario (Japan), Giuseppe Mancia (Italy), Ana Mocumbi (Mozambique), Sanjeevi N.Narasingan (India), Elijah Ogola (Kenya), Srinath Reddy (India), Ernesto Schiffrin (Canada), Ann Soenarta (Indonesia), Rhian Touyz (UK), Yudah Turana (Indonesia), Michael Weber (USA), Paul Whelton (USA), Xin Hua Zhang, (Australia), Yuqing Zhang (China).

[1]  M. Paech,et al.  The SOMANZ Guidelines for the Management of Hypertensive Disorders of Pregnancy 2014 , 2015, The Australian & New Zealand journal of obstetrics & gynaecology.

[2]  Geoffrey A Head,et al.  European Society of Hypertension position paper on ambulatory blood pressure monitoring. , 2013, Journal of hypertension.

[3]  C. Nemeroff,et al.  The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. , 1998, Archives of general psychiatry.

[4]  F. Galletti,et al.  Nutrients and Nutraceuticals for the Management of High Normal Blood Pressure: An Evidence-Based Consensus Document , 2019, High Blood Pressure & Cardiovascular Prevention.

[5]  I. Valkengoed,et al.  Mortality and Cardiovascular Risk in Patients With a History of Malignant Hypertension: A Case‐Control Study , 2014, Journal of clinical hypertension.

[6]  A. Schutte,et al.  Exploring the link between cardiovascular reactivity and end-organ damage in African and Caucasian men: the SABPA study. , 2013, American journal of hypertension.

[7]  Alexander G Logan,et al.  Hypertension Canada's 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children. , 2018, The Canadian journal of cardiology.

[8]  F. Messerli,et al.  Drug induced hypertension--An unappreciated cause of secondary hypertension. , 2015, European journal of pharmacology.

[9]  J. Staessen,et al.  Prognosis of White-Coat and Masked Hypertension: International Database of Home Blood Pressure in Relation to Cardiovascular Outcome , 2014, Hypertension.

[10]  Gavin W K Wong,et al.  Effect of cyclosporine on blood pressure. , 2010, The Cochrane database of systematic reviews.

[11]  Hawkins C. Gay,et al.  Effects of Different Dietary Interventions on Blood Pressure: Systematic Review and Meta-Analysis of Randomized Controlled Trials. , 2016, Hypertension.

[12]  V. Basevi,et al.  Standards of Medical Care in Diabetes—2012 , 2011, Diabetes Care.

[13]  K. Kario,et al.  Expert panel consensus recommendations for ambulatory blood pressure monitoring in Asia: The HOPE Asia Network , 2019, Journal of clinical hypertension.

[14]  Ana L Solano López.  Effectiveness of the Mindfulness‐Based Stress Reduction Program on Blood Pressure: A Systematic Review of Literature , 2018, Worldviews on evidence-based nursing.

[15]  S. De Geest,et al.  Adherence to Long-Term Therapies: Evidence for Action , 2003, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.

[16]  J. Neaton,et al.  Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group. , 1992, Archives of internal medicine.

[17]  D. Henderson-smart,et al.  Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. , 2014, The Cochrane database of systematic reviews.

[18]  O. Uthman,et al.  Evidence of increased blood pressure and hypertension risk among people living with HIV on antiretroviral therapy: a systematic review with meta-analysis , 2016, Journal of Human Hypertension.

[19]  S. Yusuf,et al.  Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study , 2010, The Lancet.

[20]  L. Cui,et al.  Coffee consumption and risk of hypertension: a systematic review and dose–response meta-analysis of cohort studies , 2018, Journal of Human Hypertension.

[21]  A. Schutte,et al.  Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension. , 2014, Journal of hypertension.

[22]  Nilesh J Samani,et al.  High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis , 2014, Heart.

[23]  R. Collins,et al.  Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial , 2003, The Lancet.

[24]  R. Collins,et al.  Prevention of Coronary and Stroke Events with Atorvastatin in Hypertensive Patients who have Average or Lower-than-Average Cholesterol Concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial— Lipid Lowering Arm (ASCOT-LLA): A Multicentre Randomised Controlled Trial , 2012, Drugs.

[25]  M. Bots,et al.  Medication adherence in patients with apparent resistant hypertension: findings from the SYMPATHY trial , 2018, British journal of clinical pharmacology.

[26]  Susanna Price,et al.  2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. , 2018, European heart journal.

[27]  Yutaka Imai,et al.  European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring , 2008, Journal of hypertension.

[28]  Zhong-lin Liu,et al.  A meta-analysis of effects of selective serotonin reuptake inhibitors on blood pressure in depression treatment: outcomes from placebo and serotonin and noradrenaline reuptake inhibitor controlled trials , 2017, Neuropsychiatric disease and treatment.

[29]  Mahboob Rahman,et al.  Masked Hypertension and Elevated Nighttime Blood Pressure in CKD: Prevalence and Association with Target Organ Damage. , 2016, Clinical journal of the American Society of Nephrology : CJASN.

[30]  Teemu J Niiranen,et al.  Prognosis of White-Coat and Masked Hypertension: International Database of Home Blood Pressure in Relation to Cardiovascular Outcome , 2014, Hypertension.

[31]  N. Samani,et al.  Biochemical Screening for Nonadherence Is Associated With Blood Pressure Reduction and Improvement in Adherence , 2017, Hypertension.

[32]  A. Khera,et al.  2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2019, Journal of the American College of Cardiology.

[33]  F. Messerli,et al.  Secondary arterial hypertension: when, who, and how to screen? , 2014, European heart journal.

[34]  W. Vongpatanasin.  Resistant hypertension: a review of diagnosis and management. , 2014, JAMA.

[35]  K. Reynolds,et al.  Global Disparities of Hypertension Prevalence and ControlClinical Perspective , 2016 .

[36]  D. Mehr,et al.  Medication adherence interventions among hypertensive black adults: a systematic review and meta-analysis , 2017, Journal of hypertension.

[37]  L. Malan,et al.  Quantification of systemic renin-angiotensin system peptides of hypertensive black and white African men established from the RAS-Fingerprint® , 2016, Journal of the renin-angiotensin-aldosterone system : JRAAS.

[38]  J. Wordliczek,et al.  Adverse effects of interactions between antipsychotics and medications used in the treatment of cardiovascular disorders , 2020, Pharmacological Reports.

[39]  S. Lewington.  Prospective studies collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies (vol 360, pg 1903, 2002) , 2003 .

[40]  K. Kario,et al.  Ethnic Differences in the Degree of Morning Blood Pressure Surge and in Its Determinants Between Japanese and European Hypertensive Subjects: Data From the ARTEMIS Study , 2015, Hypertension.

[41]  Sandosh Padmanabhan,et al.  Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, double-blind randomised phase 4 trial , 2016, The lancet. Diabetes & endocrinology.

[42]  David R. Williams,et al.  Blood Pressure Reactivity to Psychological Stress Predicts Hypertension in the CARDIA Study , 2004, Circulation.

[43]  Helen X. Gao,et al.  American Diabetes Association Standards of Medical Care in Diabetes 2017 , 2017, Journal of diabetes.

[44]  K. Rahimi,et al.  Resistant hypertension in times of changing definitions and treatment recommendations , 2018, Heart.

[45]  K. Narkiewicz,et al.  TREATMENT OF HYPERTENSION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) , 2012 .

[46]  M. Ashwell,et al.  Waist‐to‐height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta‐analysis , 2012, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[47]  Alessandro Filippi,et al.  Adherence to Antihypertensive Medications and Cardiovascular Morbidity Among Newly Diagnosed Hypertensive Patients , 2009, Circulation.

[48]  V. Montori,et al.  The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. , 2008, The Journal of clinical endocrinology and metabolism.

[49]  P. Lotufo,et al.  Hypertension News-Screen: Spironolactone versus Clonidine as a Fourth-Drug Therapy for Resistant Hypertension Œ The ReHOT Randomized Study (Resistant Hypertension Optimal Treatment) , 2019 .

[50]  James M. Roberts,et al.  Hypertension in Pregnancy: Executive Summary , 2013 .

[51]  M. Sabatine,et al.  2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. , 2019, European heart journal.

[52]  A. Schutte,et al.  Ethnic differences regarding arterial stiffness of 6‐8‐year-old black and white boys , 2017, Journal of hypertension.

[53]  K. Kario,et al.  Could 130/80 mm Hg Be Adopted as the Diagnostic Threshold and Management Goal of Hypertension in Consideration of the Characteristics of Asian Populations? , 2018, Hypertension.

[54]  Jie Wang,et al.  Evidence-Based Chinese Medicine for Hypertension , 2013, Evidence-based complementary and alternative medicine : eCAM.

[55]  A. L. Dal-Fabbro,et al.  Adherence to long term therapies: evidence for action , 2005 .

[56]  A. Grover,et al.  Ambiguities in the Guidelines for the Management of Arterial Hypertension: Indian Perspective with a Call for Global Harmonization , 2017, Current Hypertension Reports.

[57]  S. Yusuf,et al.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.

[58]  A. Hoes,et al.  [Guidelines on cardiovascular disease prevention in clinical practice]. , 2005, Revue medicale de Liege.

[59]  M. Stampfer,et al.  Non-Narcotic Analgesic Dose and Risk of Incident Hypertension in US Women , 2005, Hypertension.

[60]  Alan D. Lopez,et al.  Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data , 2006, The Lancet.

[61]  K. Shimamoto.  The Japanese Society of Hypertension Guidelines for the Management of Hypertension 2014 (JSH2014) , 2014 .

[62]  P. López-Jaramillo,et al.  May Measurement Month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension , 2019, European heart journal.

[63]  D. Umpierre,et al.  Effects of High-Intensity Interval Training Versus Moderate-Intensity Continuous Training On Blood Pressure in Adults with Pre- to Established Hypertension: A Systematic Review and Meta-Analysis of Randomized Trials , 2018, Sports Medicine.

[64]  E. O’Brien,et al.  Setting Thresholds to Varying Blood Pressure Monitoring Intervals Differentially Affects Risk Estimates Associated With White-Coat and Masked Hypertension in the Population , 2014, Hypertension.

[65]  L. Smeeth,et al.  Comparative effectiveness of fourth-line anti-hypertensive agents in resistant hypertension: A systematic review and meta-analysis , 2017, European journal of preventive cardiology.

[66]  G. Stergiou,et al.  Office blood pressure measurement types: Different methodology—Different clinical conclusions , 2018, Journal of clinical hypertension.

[67]  J. Primdahl,et al.  EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update , 2016, Annals of the rheumatic diseases.

[68]  F. Vanmolkot,et al.  Acute effects of sumatriptan on aortic blood pressure, stiffness, and pressure waveform , 2006, Clinical pharmacology and therapeutics.

[69]  A. López.  Effectiveness of the Mindfulness‐Based Stress Reduction Program on Blood Pressure: A Systematic Review of Literature , 2018 .

[70]  G. Lip,et al.  ESC Council on hypertension position document on the management of hypertensive emergencies. , 2018, European heart journal. Cardiovascular pharmacotherapy.

[71]  Hassan Khan,et al.  Hypertension in India: a systematic review and meta-analysis of prevalence, awareness, and control of hypertension , 2014, Journal of hypertension.

[72]  Mohammad Hosein Farzaei,et al.  Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2018, Lancet.

[73]  Francesca N. Delling,et al.  Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association , 2019, Circulation.

[74]  Daniel W. Jones,et al.  Blood Pressure Assessment in Adults in Clinical Practice and Clinic-Based Research: JACC Scientific Expert Panel. , 2019, Journal of the American College of Cardiology.

[75]  A. Shennan,et al.  Faculty Opinions recommendation of Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. , 2015 .

[76]  R. Collins,et al.  Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled tri , 2005, The Lancet.

[77]  L. Brewster,et al.  Systematic review: antihypertensive drug therapy in patients of African and South Asian ethnicity , 2016, Internal and Emergency Medicine.

[78]  T. Casale,et al.  Incidence and characteristics of angioedema associated with enalapril. , 2005, Archives of internal medicine.

[79]  J. Rehm,et al.  The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis. , 2017, The Lancet. Public health.

[80]  J. Staessen,et al.  Office blood pressure measurement in the 21st century , 2018, Journal of clinical hypertension.

[81]  A. Shennan,et al.  Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. , 2015, Obstetrics and gynecology.

[82]  Ji-Guang Wang,et al.  Are the American Heart Association/American College of Cardiology High Blood Pressure Guidelines Fit for Global Purpose?: Thoughts From the International Society of Hypertension. , 2018, Hypertension.

[83]  A. Barthel,et al.  Unrecognized secondary causes of hypertension in patients with hypertensive urgency/emergency: prevalence and co-prevalence , 2010, Clinical Research in Cardiology.

[84]  Margaret Ashwell,et al.  A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0·5 could be a suitable global boundary value , 2010, Nutrition Research Reviews.

[85]  R. Brook,et al.  Air Pollution Exposure and Blood Pressure: An Updated Review of the Literature. , 2015, Current pharmaceutical design.

[86]  T. Gomes,et al.  Fixed-dose combination antihypertensive medications, adherence, and clinical outcomes: A population-based retrospective cohort study , 2018, PLoS medicine.

[87]  A. Michael,et al.  Expert recommendations on the management of hypertension in patients with ovarian and cervical cancer receiving bevacizumab in the UK , 2019, British Journal of Cancer.

[88]  S. Solomon,et al.  Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril/valsartan (LCZ696) in patients with chronic heart failure and reduced ejection fraction: results from PARADIGM-HF , 2017, European heart journal.

[89]  L. Ruilope,et al.  Long-term renal survival in malignant hypertension. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[90]  H. Hulter,et al.  Arterial hypertension induced by erythropoietin and erythropoiesis-stimulating agents (ESA). , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[91]  R. Collins,et al.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.

[92]  K. Kario,et al.  Blood pressure monitoring: theory and practice. European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability Teaching Course Proceedings. , 2017, Blood pressure monitoring.

[93]  M. Paech,et al.  SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014 , 2015, The Australian & New Zealand journal of obstetrics & gynaecology.

[94]  G. MacGregor,et al.  Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials , 2013, BMJ : British Medical Journal.

[95]  R. Kelishadi,et al.  Establishing International Blood Pressure References Among Nonoverweight Children and Adolescents Aged 6 to 17 Years , 2016, Circulation.

[96]  G. Parati,et al.  STRIDE BP: an international initiative for accurate blood pressure measurement. , 2020, Journal of hypertension.

[97]  H. Krum,et al.  Meta-analysis of cyclooxygenase-2 inhibitors and their effects on blood pressure. , 2005, Archives of internal medicine.

[98]  R. Elston,et al.  Ethnic differences in proximal and distal tubular sodium reabsorption are heritable in black and white populations , 2009, Journal of hypertension.

[99]  G. Boysen,et al.  European Guidelines on Cardiovascular Disease Prevention , 2009, International journal of stroke : official journal of the International Stroke Society.

[100]  A. Manolis,et al.  Eplerenone Versus Spironolactone in Resistant Hypertension: an Efficacy and/or Cost or Just a Men’s Issue? , 2019, Current Hypertension Reports.

[101]  James D. Neaton,et al.  Serum Cholesterol, Blood Pressure, Cigarette Smoking, and Death From Coronary Heart Disease Overall Findings and Differences by Age for 316099 White Men , 1992 .

[102]  K. Kario.  The HOPE Asia Network for “zero” cardiovascular events in Asia , 2018, Journal of clinical hypertension.

[103]  Hynek Pikhart,et al.  Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants , 2017, The Lancet.

[104]  V. Conn,et al.  Medication adherence outcomes of 771 intervention trials: Systematic review and meta-analysis. , 2017, Preventive medicine.

[105]  D. Prabhakaran,et al.  May Measurement Month 2017: an analysis of blood pressure screening results worldwide. , 2018, The Lancet. Global health.

[106]  Jiang He,et al.  Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries. , 2015, Circulation.

[107]  B. Nordestgaard.  Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology. , 2016, Circulation research.

[108]  D. Fitzgerald,et al.  Traditional Herbal Medicine Use Among Hypertensive Patients in Sub-Saharan Africa: A Systematic Review , 2014, Current Hypertension Reports.

[109]  R. Brook,et al.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2018, Journal of the American Society of Hypertension : JASH.

[110]  V. Cornelissen,et al.  Exercise Training for Blood Pressure: A Systematic Review and Meta‐analysis , 2013, Journal of the American Heart Association.

[111]  J. Staessen,et al.  Diagnosis and management of resistant hypertension: state of the art , 2018, Nature Reviews Nephrology.

[112]  Roberto Sega,et al.  Long-Term Risk of Mortality Associated With Selective and Combined Elevation in Office, Home, and Ambulatory Blood Pressure , 2006, Hypertension.

[113]  Thomas Kahan,et al.  [2018 ESC/ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)]. , 2018, Giornale italiano di cardiologia.

[114]  Viola Vaccarino,et al.  Effects of Different Dietary Interventions on Blood Pressure: Systematic Review and Meta-Analysis of Randomized Controlled Trials. , 2016, Hypertension.

[115]  G. A. Leng.  ON POPULATION. , 1963, Singapore medical journal.

[116]  N. Powe,et al.  Excess risk of chronic kidney disease among African-American versus white subjects in the United States: a population-based study of potential explanatory factors. , 2002, Journal of the American Society of Nephrology : JASN.

[117]  A. Domínguez-Rodríguez,et al.  Comparison of Dual Therapies for Lowering Blood Pressure in Black Africans. , 2019, The New England journal of medicine.

[118]  L. Opie,et al.  Hypertension in Sub-Saharan African Populations , 2005, Circulation.

[119]  S. Oparil,et al.  Prevalence of pseudoresistant hypertension due to inaccurate blood pressure measurement. , 2016, Journal of the American Society of Hypertension : JASH.

[120]  N. Hasebe,et al.  Impact of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guidelines on the Next Blood Pressure Guidelines in Asia , 2019, Current Hypertension Reports.

[121]  A. Pessina,et al.  Drug-related hypertension and resistance to antihypertensive treatment: a call for action , 2011, Journal of hypertension.

[122]  S. Vollmer,et al.  The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1·1 million adults , 2019, The Lancet.

[123]  Inge Christoffer Olsen,et al.  Guideline recommended treatment to targets of cardiovascular risk is inadequate in patients with inflammatory joint diseases. , 2019, International journal of cardiology.

[124]  F. Zitman,et al.  Depression Is Associated With Decreased Blood Pressure, but Antidepressant Use Increases the Risk for Hypertension , 2009, Hypertension.

[125]  Yoshihiko Kanno,et al.  The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019) , 2019, Hypertension Research.

[126]  K. Sliwa,et al.  Comparison of Dual Therapies for Lowering Blood Pressure in Black Africans. , 2019, The New England journal of medicine.

[127]  J. Prochaska,et al.  National Blood Pressure Reference for Chinese Han Children and Adolescents Aged 7 to 17 Years , 2017, Hypertension.

[128]  D. Webb,et al.  Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies , 2018, The lancet. Diabetes & endocrinology.

[129]  K. Goessler,et al.  The blood pressure-lowering effect of a single bout of resistance exercise: A systematic review and meta-analysis of randomised controlled trials , 2016, European journal of preventive cardiology.

[130]  W. Young,et al.  The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline. , 2016, The Journal of clinical endocrinology and metabolism.

[131]  Kristen M. Fedak,et al.  Acute Effects on Blood Pressure Following Controlled Exposure to Cookstove Air Pollution in the STOVES Study , 2019, Journal of the American Heart Association.

[132]  A. Manolis.  Faculty Opinions recommendation of Spironolactone Versus Clonidine as a Fourth-Drug Therapy for Resistant Hypertension: The ReHOT Randomized Study (Resistant Hypertension Optimal Treatment). , 2020 .

[133]  S. Bangalore,et al.  The Blood Pressure Landscape: Schism Among Guidelines, Confusion Among Physicians, and Anxiety Among Patients. , 2018, Journal of the American College of Cardiology.

[134]  J. Manson,et al.  Prospective study of oral contraceptives and hypertension among women in the United States. , 1996, Circulation.

[135]  Aditya M. Sharma,et al.  First International Consensus on the diagnosis and management of fibromuscular dysplasia , 2019, Vascular medicine.

[136]  Isla Mackenzie,et al.  Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial , 2015, The Lancet.

[137]  S. Daniels,et al.  Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents , 2017, Pediatrics.

[138]  Gretchen A. Stevens,et al.  Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys , 2019, The Lancet.

[139]  Zuo Chen,et al.  Status of Hypertension in China: Results From the China Hypertension Survey, 2012–2015 , 2018, Circulation.

[140]  A. Viera,et al.  Diagnosis of secondary hypertension: an age-based approach. , 2010, American family physician.

[141]  S. Patten,et al.  Major Depression as a Risk Factor for High Blood Pressure: Epidemiologic Evidence From a National Longitudinal Study , 2009, Psychosomatic medicine.

[142]  Mike Kirby,et al.  Guidelines on the management of cardiovascular diseases during pregnancy The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology ( ESC ) , 2011 .

[143]  V. Conn,et al.  Interventions to Improve Medication Adherence in Hypertensive Patients: Systematic Review and Meta-analysis , 2015, Current Hypertension Reports.

[144]  N. Benowitz,et al.  Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids , 2000 .

[145]  G. Bakris,et al.  Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. , 2008, The New England journal of medicine.

[146]  N. Chapman,et al.  Effect of Doxazosin Gastrointestinal Therapeutic System as Third-Line Antihypertensive Therapy on Blood Pressure and Lipids in the Anglo-Scandinavian Cardiac Outcomes Trial , 2008, Circulation.

[147]  A. Dominiczak,et al.  Serum uric acid and the risk of cardiovascular and renal disease. , 2015, Journal of hypertension.

[148]  K. Sliwa,et al.  Roadmap to achieve 25% hypertension control in Africa by 2025 , 2017, Cardiovascular journal of Africa.

[149]  A. Khera,et al.  2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2019, Journal of the American College of Cardiology.

[150]  Nicola Persico,et al.  Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia , 2017, The New England journal of medicine.

[151]  G. Eslick,et al.  The association between consistent licorice ingestion, hypertension and hypokalaemia: a systematic review and meta-analysis , 2017, Journal of Human Hypertension.

[152]  José R Fernández,et al.  Cardiovascular Risk of Resistant Hypertension: Dependence on Treatment-Time Regimen of Blood Pressure–Lowering Medications , 2013, Chronobiology international.

[153]  Alessandro Monaco,et al.  Interventional tools to improve medication adherence: review of literature , 2015, Patient preference and adherence.

[154]  D. Prabhakaran,et al.  Is It Time to Reappraise Blood Pressure Thresholds and Targets? A Statement From the International Society of Hypertension-A Global Perspective. , 2016, Hypertension.

[155]  R. Townsend,et al.  Blood Pressure Control 1 Year After Referral to a Hypertension Specialist , 2013, Journal of clinical hypertension.

[156]  R. Horne,et al.  How to Screen for Non-Adherence to Antihypertensive Therapy , 2016, Current Hypertension Reports.

[157]  K. Kario,et al.  Seasonal variation in blood pressure: Evidence, consensus and recommendations for clinical practice. Consensus statement by the European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability. , 2020, Journal of hypertension.

[158]  G. Mancia,et al.  Better compliance to antihypertensive medications reduces cardiovascular risk , 2011, Journal of hypertension.

[159]  G. Bakris,et al.  The double challenge of resistant hypertension and chronic kidney disease , 2015, The Lancet.

[160]  N. Samani,et al.  Risk Factors for Nonadherence to Antihypertensive Treatment , 2017, Hypertension.

[161]  S. Salerno,et al.  Effect of oral pseudoephedrine on blood pressure and heart rate: a meta-analysis. , 2005, Archives of internal medicine.

[162]  G. V. van Montfrans,et al.  Ethnic disparities in the incidence, presentation and complications of malignant hypertension , 2006, Journal of hypertension.

[163]  M. Taskinen,et al.  [ESC/EAS Guidelines for the management of dyslipidaemias]. , 2011, Revista espanola de cardiologia.